M&A Deal Summary

MegaGen Acquires Biolase

On September 10, 2025, MegaGen acquired medical products company Biolase for 20M USD

Acquisition Highlights
  • This is MegaGen’s 1st transaction in the Medical Products sector.
  • This is MegaGen’s largest (disclosed) transaction.
  • This is MegaGen’s 1st transaction in the United States.
  • This is MegaGen’s 1st transaction in California.

M&A Deal Summary

Date 2025-09-10
Target Biolase
Sector Medical Products
Buyer(s) MegaGen
Deal Type Special Situations/Distressed
Deal Value 20M USD

Target

Biolase

Foothill Ranch, California, United States
Biolase is a dental laser technology, manufacturing high-performance laser systems that advance dentistry and improve patient experiences. Biolase is based in Foothill Ranch, California.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

MegaGen

Daegu, South Korea

Category Company
Sector Medical Products
DESCRIPTION

MegaGen is a medical equipment supplier that exports to Europe and the US within the Korean market. The company offers patented surface treatment technology, called “XPEED,” which gives the implants a distinctive blue surface, unlike the typical gray color. This process incorporates calcium ions and forms a nanosturucture that promotes faster bone growth and healing while removing acid residues from the surface. MegaGen is based in Daegu, South Korea.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Special Situations/Distressed M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1
Size (of disclosed) 1 of 1